1998
DOI: 10.1006/viro.1998.9031
|View full text |Cite
|
Sign up to set email alerts
|

The Significance of the 3′-Nontranslated Region and E2 Amino Acid Mutations in the Virulence of Semliki Forest Virus in Mice

Abstract: We have recently shown that the 3'-nontranslated region (3'-NTR) of the avirulent Semliki Forest virus A7(74) [SFVA7(74)] contains a unique sequence of 101 nucleotides and five repetitive nucleotide units whereas the 3'-NTR of the neurovirulent SFV4 has only two repeats. A chimeric virus was constructed by replacing the entire 3'-NTR of the SFV4 clone with the A7(74) 3'-NTR. The hybrid replicated efficiently in the central nervous system (CNS) of adult Balb/c mice and, similarly to SFV4, led to high mortality … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 35 publications
0
11
0
Order By: Relevance
“…Several series of SFV mutants, including temperature-sensitive (ts) mutants, have been described (Tan et al, 1969;Keranen and Kaariainen, 1974;Hearne et al, 1987;Barrett et al, 1980). A number of strains including prototype, which is related to L10, A7, and A7(74), have been cloned and sequenced (Garoff et al, 1980;Takkinen, 1986;Glasgow et al, 1994;Santagati et al, 1995Santagati et al, , 1998Tarbatt et al, 1997;Tuittila et al, 2000). The molecular clone of the prototype strain, known as SFV4, has been engineered to form a much used viral expression and vaccine system (Liljestrom and Garoff, 1991;Tubulekas et al, 1997).…”
Section: Strains Of Sfvmentioning
confidence: 99%
“…Several series of SFV mutants, including temperature-sensitive (ts) mutants, have been described (Tan et al, 1969;Keranen and Kaariainen, 1974;Hearne et al, 1987;Barrett et al, 1980). A number of strains including prototype, which is related to L10, A7, and A7(74), have been cloned and sequenced (Garoff et al, 1980;Takkinen, 1986;Glasgow et al, 1994;Santagati et al, 1995Santagati et al, , 1998Tarbatt et al, 1997;Tuittila et al, 2000). The molecular clone of the prototype strain, known as SFV4, has been engineered to form a much used viral expression and vaccine system (Liljestrom and Garoff, 1991;Tubulekas et al, 1997).…”
Section: Strains Of Sfvmentioning
confidence: 99%
“…e A7 strain has been sequenced and the sequence compared to the more virulent prototype strain [63][64][65][66]. One of the most marked features of the A7 sequence is the presence of a long untranslated sequence containing multiple repeats at the 3 � end of the genome.…”
Section: Analysis Of Virulencementioning
confidence: 99%
“…is region is 334 nucleotides longer than in the prototype strain. However, it has no in�uence on virulence [64]. ere are multiple mutations throughout the A7 genome compared to the prototype strain, and a large proportion result in amino acid substitutions.…”
Section: Analysis Of Virulencementioning
confidence: 99%
“…Infection with the SFV A7(74) strain is lethal only for mice younger than 2 weeks, whereas in older mice, virus spread is severely restricted in CNS neurons and infection remains asymptomatic (Fazakerley et al, 1993;Oliver et al, 1997); transient demyelination of axons is observed occasionally (Amor et al, 1996;Pathak et al, 1983). In a number of alphaviruses, mutations introduced into the glycoproteins alter virulence; for example, a derivative of virulent SFV4 expressing the A7(74) E2 glycoprotein is apathogenic for adult mice (Santagati et al, 1995) and single amino acid mutations in the E2 protein attenuate the virus (Santagati et al, 1998). However, as shown by our previous experiments, replacement of the entire structural region of SFV4 with that of A7(74) yields a fully lethal virus, while a reciprocal SFV recombinant is avirulent , thus proving the importance of the nonstructural protein genes for virulence.…”
Section: Introductionmentioning
confidence: 99%